Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 90
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Chloride deregulation and GABA depolarization in MTOR-related malformations of cortical development

Chloride deregulation and GABA depolarization in MTOR-r...

 102

Glycocalyx dysregulation impairs blood– brain barrier in ageing and disease

Glycocalyx dysregulation impairs blood– brain barrier i...

 193

Ubiquitin precursor with C-terminal extension promotes proteostasis and longevity

Ubiquitin precursor with C-terminal extension promotes ...

 63